MD MEDNAX Inc.

MEDNAX to Present as a Corporate Partner at Becker’s Hospital Review 8th Annual Meeting

MEDNAX, Inc., (NYSE: MD), the national health solutions partner specializing in anesthesiology, neonatology, maternal-fetal medicine, other pediatric services, radiology, and management services is exhibiting at the Becker’s Hospital Review 8th Annual Meeting from April 17-19, 2017 at the Hyatt Regency in Chicago. Physicians and leadership from MEDNAX will be on site at Booth #609.

Speakers from Surgical Directions, a MEDNAX company, will also be presenting:

BREAKFAST LUNCH & LEARN:

Improving the performance of your systems most financially attractive services line -

Perioperative Services

Wednesday, April 19 from 7:00-8:00 a.m.

Jeff Peters, Chief Executive Officer, Surgical Directions

Using Predictive Analytics to Increase Your Hospital’s Profitability

Wednesday, April 19 from 1:50-2:30 p.m.

Jeff Peters, Chief Executive Officer, Surgical Directions

Michael Besedick, Business Consultant, Surgical Directions

The Becker’s Hospital Review 8th Annual Meeting is an exclusive conference that brings together hospital business and strategy leaders to discuss how to improve hospitals and their bottom lines in these challenging but opportunity-filled times. The best minds in the hospital field will discuss opportunities, and provide practical and immediately useful guidance on ACOs, physician-hospital integration, improving profitability and key specialties.

ABOUT MEDNAX

MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,725 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a management services organization and a consulting services company. Additional information is available at www.mednax.com.

EN
12/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MEDNAX Inc.

Pediatrix Medical Group Inc.: 1 director

A director at Pediatrix Medical Group Inc. sold 23,000 shares at 22.410USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Mednax, Inc.: Covenant Quality Post-Sale Snapshot: $400m 5.375% Senior...

Mednax. Inc.’s covenant package provides lower-tier HY-Lite protection, reflecting a covenant quality score of 5.00.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch